Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Non-Current Assets: 2009-2025

Historic Non-Current Assets for Gyre Therapeutics (GYRE) over the last 17 years, with Sep 2025 value amounting to $60.8 million.

  • Gyre Therapeutics' Non-Current Assets fell 13.66% to $60.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.8 million, marking a year-over-year decrease of 13.66%. This contributed to the annual value of $60.6 million for FY2024, which is 2.19% up from last year.
  • Gyre Therapeutics' Non-Current Assets amounted to $60.8 million in Q3 2025, which was down 0.90% from $61.4 million recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Non-Current Assets registered a high of $70.4 million during Q3 2024, and its lowest value of $773,000 during Q3 2022.
  • Its 3-year average for Non-Current Assets is $46.8 million, with a median of $60.6 million in 2024.
  • Per our database at Business Quant, Gyre Therapeutics' Non-Current Assets plummeted by 83.10% in 2022 and then surged by 1,357.60% in 2024.
  • Gyre Therapeutics' Non-Current Assets (Quarterly) stood at $4.2 million in 2021, then spiked by 738.51% to $35.1 million in 2022, then skyrocketed by 69.00% to $59.3 million in 2023, then increased by 2.19% to $60.6 million in 2024, then dropped by 13.66% to $60.8 million in 2025.
  • Its Non-Current Assets was $60.8 million in Q3 2025, compared to $61.4 million in Q2 2025 and $61.3 million in Q1 2025.